Watch Christina's presentation discussing our investment thesis on Precigen, the company's recent progress, and why we believe it remains an attractive long-term opportunity.
FOR INSTITUTIONAL USE ONLY
This information does not constitute, and should not be construed as, investment advice or recommendations with respect to the securities and sectors listed. All investments are subject to risk, including the possible loss of principal. There is no guarantee investment objectives will be met. Neither Patient Capital Management, nor its information providers are responsible for any damages or losses arising from any use of this information.
The views expressed in this commentary reflect those of Patient Capital Management analyst(s) as of the date of the commentary. Any views are subject to change at any time based on market or other conditions, and Patient Capital Management disclaims any responsibility to update such views. The information presented should not be considered a recommendation to purchase or sell any security and should not be relied upon as investment advice. It should not be assumed that any purchase or sale decisions will be profitable or will equal the performance of any security mentioned. References to specific securities are for illustrative purposes only. The specific stock(s) were selected to illustrate our investment philosophy and are not intended as a, solicitation, or recommendation of any particular security or investment strategy.
The commentary herein is intended for informational purposes only and does not constitute investment, legal, or tax advice or an offer to sell, or a solicitation of an offer to buy, securities, or an endorsement with respect to any investment strategy or vehicle managed by the Firm.
Past performance is no guarantee of future results.
©2026 Patient Capital Management, LLC
Share